Skip to Main Content
American Flag
JULY 4TH SALE

50% off your first year of Quiver Premium

...

Use Promo Code:

JULY4
American Flag

Amneal Pharmaceuticals, Inc. Class A Common Stock

AMRX Real Time Price USD
N/A
N/A
N/A
...
...
Overview
Financials
Forecast
Insiders
Institutions
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown
AMRX Stock Insider Trading Activity Follow @QuiverQuant for major insider updates
Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
AMRX Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
AMRX Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes by institutional investors

Quarterly net insider trading by AMRX's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions
  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

  • $910,000 Apr 21, 2025 Issue: Health Issues
  • $210,000 Jan 21, 2025 Issue: Health Issues
  • $230,000 Jan 21, 2025 Issue: Health Issues
  • $240,000 Jan 21, 2025 Issue: Health Issues
  • $850,000 Jan 21, 2025 Issue: Health Issues
  • $40,000 Apr 20, 2022 Issue: Pharmacy
  • $60,000 Jan 20, 2022 Issue: Pharmacy
  • $60,000 Oct 20, 2021 Issue: Pharmacy
  • $60,000 Jul 20, 2021 Issue: Pharmacy
  • $60,000 Apr 20, 2021 Issue: Pharmacy
  • $60,000 Jan 21, 2021 Issue: Pharmacy
  • $60,000 Oct 20, 2020 Issue: Pharmacy
  • $50,000 Jul 20, 2020 Issue: Pharmacy
  • $20,000 Feb 01, 2019 Issue: None
  • $20,000 Jan 18, 2019 Issue: None
  • $20,000 Oct 08, 2018 Issue: None
  • $20,000 Jul 12, 2018 Issue: None
  • $40,000 Apr 16, 2018 Issue: Health Issues Budget/Appropriations
  • $40,000 Jan 20, 2018 Issue: Trade (domestic/foreign) Health Issues
  • $40,000 Dec 28, 2017 Issue: Health Issues
  • $40,000 Oct 19, 2017 Issue: Health Issues
  • $40,000 Jul 19, 2017 Issue: Health Issues
  • $40,000 Apr 20, 2017 Issue: Health Issues
  • $40,000 Oct 20, 2016 Issue: Pharmacy Health Issues
  • $40,000 Jul 19, 2016 Issue: Health Issues Pharmacy
  • $40,000 Apr 14, 2016 Issue: Pharmacy Health Issues
  • $40,000 Jan 15, 2016 Issue: Pharmacy Budget/Appropriations Copyright/Patent/Trademark Health Issues
  • $40,000 Oct 19, 2015 Issue: Pharmacy Health Issues Copyright/Patent/Trademark
  • $40,000 Jul 14, 2015 Issue: Pharmacy Health Issues Budget/Appropriations
  • $10,000 Apr 17, 2015 Issue: Health Issues Medicare/Medicaid Budget/Appropriations Pharmacy
  • $40,000 Apr 17, 2015 Issue: Health Issues Budget/Appropriations Pharmacy
  • $30,000 Jan 20, 2015 Issue: Pharmacy
  • $20,000 Jan 18, 2015 Issue: Insurance Health Issues Taxation/Internal Revenue Code Medicare/Medicaid Budget/Appropriations Pharmacy
  • $10,000 Oct 18, 2014 Issue: Pharmacy Taxation/Internal Revenue Code Health Issues Budget/Appropriations Insurance Food Industry (safety, labeling, etc.) Medicare/Medicaid
  • $30,000 Oct 15, 2014 Issue: Pharmacy
  • $30,000 Jul 18, 2014 Issue: Pharmacy Health Issues Budget/Appropriations
  • $30,000 Apr 16, 2014 Issue: Pharmacy Health Issues Budget/Appropriations
  • $25,000 Jan 16, 2014 Issue: Budget/Appropriations Health Issues Pharmacy

Estimated quarterly lobbying spending

AMRX Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
AMRX Income Statement
AMRX Balance Sheet
AMRX Cash Flow
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Estimated quarterly amount awarded from public contracts

AMRX News

Recent insights relating to AMRX

CNBC Recommendations

Recent picks made for AMRX stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in AMRX

AMRX Analyst Ratings

AMRX Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
AMRX Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $AMRX stock a Buy, Sell, or Hold?

  • What is the price target for $AMRX stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

AMRX Top Shareholders
Shareholder
Shares Held
AMRX Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $AMRX stock?

  • Who owns the most shares of $AMRX stock?

  • What funds own $AMRX stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

AMRX Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view AMRX Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top